Project Grant HT94252411039
Award Date
11/1/24
Completion Date
10/31/27
Dollars Obligated
$998K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Hanover, NH 03755, USA
Similar Awards
The federal Project Grant award, totaling $999,972.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Feinstein Institutes For Medical Research. The grant supports a study focused on "Studying Urine Macrophages in Lupus Nephritis to Shed Light on Kidney Disease Processes." The research aims to advance the understanding of lupus nephritis, a serious kidney condition, by examining immune cells in urine samples....
This $299,322 Project Grant award, issued by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program, supports research on the biology of hydrolyzed C3 in systemic lupus erythematosus (SLE). The principal investigator and awardee is The Washington University, a prominent private research institution located in St. Louis, Missouri. The award period runs from August 1, 2024 to July 31, 2026. The research aims to advance scientific...
This $299,998 Project Grant award was provided by the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) to the University of Nebraska Medical Center (UNMC). The award will support a 2-year research project from July 2024 to July 2026 entitled "VAP-1 AND METHYLGLYOXAL AS NOVEL TARGETS IN LUPUS NEPHRITIS". Through this funding, UNMC will conduct innovative biomedical research to investigate new treatment approaches for lupus nephritis, a...
The Department of Defense's Military Medical Research and Development (CFDA 12.420) program awarded a $300,000 Project Grant to Duke University to investigate the "Complement-Activating Properties of Anti-Sm/RNP Antibodies in SLE". This 2-year research effort, starting on September 1, 2024 and ending on August 31, 2026, aims to advance biomedical research that can transform healthcare for military service members, veterans, and the broader public. The Military Medical Research and...
The Project Grant award of $1,000,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award will support research conducted by The Feinstein Institutes for Medical Research, a leading non-profit medical research organization, to investigate the neural substrates of fatigue and impaired cognition in individuals with lupus, a condition also known as "lupus brain fog." The research aims to advance...
This $750,000 federal Project Grant award from the Department of Defense's Defense Health Agency supports research by Vanderbilt University Medical Center (VUMC) on small RNAs and the heterogeneity of risk for developing systemic lupus erythematosus. The award is funded through the Military Medical Research and Development program (CFDA 12.420), which focuses on biomedical research related to military medicine. VUMC, a leading academic medical center and nonprofit healthcare provider, will...
This Project Grant award of $300,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research at Tulane University to determine risk factors for lupus nephritis through the intersection of glycobiology and immunometabolism. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative and impactful medical solutions. The award period runs from August 15, 2025 to...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $299,937.00 to The Feinstein Institutes For Medical Research to conduct research on visualizing neural synaptic density in systemic lupus erythematosus (SLE) to better understand mechanisms of brain dysfunction. The award period runs from July 15, 2024 to July 14, 2026. The Feinstein Institutes, a non-profit research organization, will utilize this...
The Defense Health Agency awarded a $1,000,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Jackson Laboratory in Bar Harbor, Maine. The grant will support research to uncover spatial and temporal alterations of metabolism in the kidney, which could pave the way for new treatments for lupus nephritis. The project will be conducted over a 3-year period from May 2025 to May 2028. Jackson Laboratory, a nonprofit biomedical research institution,...
The University of Houston was awarded a $750,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research into interleukin-15 (IL-15) in lupus from September 30, 2021 through September 29, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care through innovative...